Alimentary Pharmacology and Therapeutics
Aerobic Exercise Could Have the Final Say on Fatty Livers
by Shari Barbanel |
August 3, 2020
A new study from Trinity College Dublin (Ireland) highlights that fitness may be a more important clinical endpoint for improvement in patients with fatty liver diseases during exercise trials, rather than weight loss. The findings have been published in the medical journal Alimentary Pharmacology and Therapeutics. Metabolic associated fatty liver disease (MAFLD) is a condition characterized ...
Don't Miss Out!
Digital Newsletter
Natural Practitioner Magazine
Industry Professionals
Stay Informed!
Stay informed about the latest health, nutrition, and wellness developments by signing up for a FREE subscription to Natural Practitioner magazine and digital newsletter.
Once subscribed, you will receive industry insights, product trends, and important news directly to your doorstep and inbox.
